This inventor holds 2 USPTO granted patents. Top assignee: G.d. Searle & Company. Active years: 1990-2006.
Company Filing History:
Years Active: 1990-2006
Title: Ellen G McMahon: Innovator in Cardiac Treatment
Introduction
Ellen G McMahon is a prominent inventor based in St. Louis, MO (US). She has made significant contributions to the field of cardiac treatment, holding 2 patents that focus on innovative therapeutic methods.
Latest Patents
Her latest patents include a method to treat cardiofibrosis with a combination therapy of an angiotensin II antagonist and epoxymexrenone. This therapeutic method is designed for treating cardiofibrosis or cardiac hypertrophy using a combination therapy comprising a therapeutically-effective amount of an angiotensin II receptor antagonist and a therapeutically-effective amount of epoxymexrenone. Additionally, she has developed a class of 8-azapurin-6-one derivatives for the control of hypertension, with a particular focus on the compound 8-aza-2-(2-n-propoxyphenyl)purin-6-one.
Career Highlights
Ellen G McMahon has worked at G.D. Searle & Company, where she has been able to apply her innovative ideas in a professional setting. Her work has contributed to advancements in medical treatments, particularly in cardiology.
Collaborations
She has collaborated with notable coworkers such as Gillian M Olins and Robert E Manning, further enhancing her research and development efforts.
Conclusion
Ellen G McMahon's contributions to cardiac treatment through her patents demonstrate her commitment to innovation in the medical field. Her work continues to impact the lives of many individuals suffering from cardiac conditions.